SCHW

Outcome

—

Return

—

Status

—

Subscribe to read

Outcome

—

Return

—

Status

—

Subscribe to read

Outcome

✗

Return

-0.18%

Status

scored

Overweight SCHW with 1–1.5% initial position at $95.50–$97.00, deferring full 2.5–3% Tier 1 deployment until Q3 earnings clears the binary catalyst in mid-to-late October. Entry triggers include RSI <30 with bullish divergence for Tier 2 adds at $92.50–$93.50, with a hard stop at $90 close; the $90 puts hedge (1–2% of position cost, 3-month tenor) neutralizes path-risk to $87–92 if the lower Bollinger breaks.

Outcome

✗

Return

+1.35%

Status

scored

Override the unanimous Hold consensus with an Underweight rating at 50-60% of benchmark weight, defaulting to the aggressive end of the band per the 10/06 binding reflection. The decisive 200 SMA break at $97.88 (current ~$95.58) with Q3 earnings 2-3 weeks out triggers the Underweight directive, overriding analyst consensus. Buy $90 3-month puts as hedge against the $87-92 path risk; stop-loss at $87 closing.

Outcome

✓

Return

-1.26%

Status

scored

SCHW has been downgraded to Underweight at 60-70% of benchmark weight following the decisive break of the 200 SMA at $97.89 (closing $96.80, $1.09 below), with three consecutive Holds at this technical level confirming documented alpha destruction of 1.2-2.4% each. The measured Underweight executes the 10/05 binding reflection's trigger-fire instruction while preserving structural bid exposure (11B annualized buyback, 96% Polymarket no-cut probability) that precludes full Underweight or Sell per the 10/02 lesson, with stop-loss at $92.50 and upgrade trigger at Q3 beat-and-raise with 10 EMA reclaim at $98.88.

Outcome

✓

Return

-1.18%

Status

scored

SCHW maintains neutral-weight Hold with no new capital deployment into the 200 SMA test at $97.88, as the 9/21 binding categorically prohibits staged adds during technical deterioration with distant Q3 earnings catalyst (mid-October). The $94.50 closing stop is properly ATR-buffered at 1.43x; upgrade to Overweight requires Q3 beat-and-raise with close above $102.72, while downgrade to Underweight triggers on close below $97.00 with volume above 8M shares.

Outcome

✗

Return

+1.30%

Status

scored

Reduce SCHW to 50–60% of neutral benchmark weight, converting from Hold to Underweight as the technical trigger architecture has fired with price below both the $99 preemptive trigger and the 200 SMA at $97.84, while empirically confirming the alpha-bleed pathology with two consecutive Hold decisions producing -1.2% and -2.4% alpha. The position should be trimmed incrementally over the next two sessions based on price action, with a $92.00 stop-loss on the residual position and potential hedging via 3-month $90 puts ahead of Q3 earnings in approximately two weeks.

Outcome

✓

Return

-1.70%

Status

scored

SCHW maintains HOLD at neutral weight as the synthesis that survives fundamental quality, technical posture, and reflection hierarchy tests. Both aggressive BUY and conservative Underweight are rejected—Aggressive's bull case overstates buyback support by ~35% and misframes the 200 SMA as defended when it faces its first real test, while Conservative's technical critique, though valid, overreaches by pushing below neutral weight on a franchise with 20.3% ROE and ~$10.95B buyback program just $0.10 below the 200 SMA with Q3 earnings 10-14 days out. Stop-loss refined to $94.50 closing (ATR-buffered), with explicit two-sided triggers at $102.72 (upgrade), $99/$97 (downgrade), and $92 (sell) that activate the discipline passive Holds have historically lacked.

Outcome

✓

Return

+0.64%

Status

scored

Maintain SCHW at current sizing with NO new capital deployment despite technically attractive fundamentals; price has breached the 200 SMA on a closing basis ($97.74 vs. $97.84), triggering the binding 9/21 reflection that requires defaulting to Hold with explicit invalidation triggers rather than staged adds when technical deterioration collides with distant catalysts. All three proposed entries (50% initiation, 25-30% starter, and staged accumulation) replicate the exact architecture that produced the -6.1% alpha failure on 9/21, and the binary Q3 earnings catalyst ~2 weeks out counsels letting technicals resolve before deployment.

Outcome

✓

Return

-1.37%

Status

scored

Maintain SCHW at current sizing with NO new capital deployment at any level. The 9/21 binding reflection explicitly prohibits staged adds when technical deterioration (MACD deeply negative, RSI ~33, below all major MAs) meets a distant catalyst (Q3 earnings ~3 weeks out), and this setup is materially identical to the 9/28 Hold that generated +1.0% alpha. Trigger architecture preserves alpha: close <$97.83 with volume >8M triggers Underweight; close >$102.72 with MACD narrowing + Q3 beat triggers Overweight.

Outcome

✓

Return

+0.81%

Status

scored

Maintain SCHW at neutral weight with no incremental capital deployment ahead of Q3 earnings in mid-October. The fundamental pillars (12.55x forward P/E, PEG less than 1.0, 20% ROE, 42% EPS growth, 8%+ capital return yield) are strong, but technical deterioration with a distant catalyst and binding reflection history prohibit staged adds. Hold with explicit trigger architecture—upgrade triggers at $102.72, downgrade triggers at $97.00—preserves alpha versus passive drift.

Outcome

✓

Return

-0.74%

Status

scored

Maintain SCHW at ~$99 with HOLD rating pending Q3 earnings mid-October. The binding 9/24 reflection explicitly invalidated trim-into-strength and asymmetric-downside framing when technical breakdowns occur near well-supported moving averages—the 200 SMA at $97.79 has held through three prior tests. Upgrade triggers include Q3 beat-and-raise with close above $102.72 plus MACD cross; downgrade to Underweight triggers on close below $97 with volume above 8M shares; downgrade to Sell on close below $92 or Q3 NII below $3.2B.

Outcome

✓

Return

-0.46%

Status

scored

SCHW receives Underweight rating (50-75% of benchmark) with a directive to trim 20-25% of the position into the $104-106 resistance zone (10 EMA/50 SMA confluence) rather than waiting for the 200 SMA test at $97.70 to resolve. The hard stop on any residual position is set at $97.50 close, with Q3 earnings in mid-October identified as the resolution catalyst for this 1-3 month tactical call.

Outcome

–

Return

-0.01%

Status

scored

SCHW is downgraded to Underweight with a target to trim 25-40% on any rally toward $104-106 (10 EMA resistance zone), with a hard stop at $97.00 (below the 200 SMA at $97.73). The technical setup is confirmed by multiple indicators—MACD expanding negative, two closes below the lower Bollinger band on 16.9M shares, RSI at 32 with no bullish divergence—while AI-disruption narrative risk represents a multi-quarter overhang. The position should be reduced to 50-75% of benchmark weight until Q3'26 earnings mid-October or until the 200 SMA is successfully reclaimed.

Outcome

✓

Return

-0.85%

Status

scored

Maintain SCHW at current sizing with no new capital deployment until either the 200 SMA at $97.70 holds on a daily close with reversal candle and volume confirmation, or the 50 SMA at $106-$108 is reclaimed with MACD histogram positive cross and volume >8M shares. A close below $97.70 on volume >15M shares triggers an immediate trim to Underweight with cascade target $92-$94. Q3 earnings in mid-October (~3-4 weeks) is the binary catalyst.

Outcome

✗

Return

-6.11%

Status

scored

SCHW is upgraded from Hold to Overweight with a staged entry strategy, initiating Tier 1 at 1.0% portfolio weight given the stock trades 9.4% above a rising 200 SMA with intact fundamentals (42% EPS growth, 20% ROE, 8% capital return yield). Stop is placed at $102.50 (1.85 ATR), with Tier 2 reserved for a pullback to $103.65-$104.50 on RSI <40 bounce confirmation, and Tier 3 for breakout above $108.23 on volume >8M shares; total capped exposure is 2.5% ahead of the Q3 earnings catalyst in mid-October.

Outcome

✗

Return

+1.55%

Status

scored

Maintain SCHW at Hold ($106) with $120 target ahead of mid-October Q3 earnings catalyst; stage 25% position add on confirmed bounce from $103-104 support (daily close above $103, RSI rising, MACD histogram contracting) or 50% add on flush to 200 SMA at $97.58 with two consecutive closes and RSI below 30 with bullish divergence; cap total exposure at 2× current size with hard stop at $102.50.

Outcome

✗

Return

+0.59%

Status

scored

Trim SCHW by 20-25% over 5-10 sessions starting at current $104-105 levels, scaling additional sales into rallies toward $107 (10 EMA/50 SMA confluence). Set hard stop at $102 on remaining core, with $95 puts as tail insurance. Re-evaluate if price reclaims $107 with bullish MACD histogram cross and volume >8M shares, or accelerate exit if close <$103.50 on volume. Time horizon anchored to Q3 2026 earnings mid-October.

Outcome

✓

Return

-0.50%

Status

scored

Maintain SCHW at current sizing (post-9/14 trim) while avoiding adds at $105.16 levels due to unresolved multi-indicator momentum breakdown (MACD negative cross, RSI 41.57, 50 SMA flipped to resistance), and avoid further trims given the 20-25% already executed was calibrated. Hard stop at $97.45 (200 SMA); add-triggers at $107.47 reclaim with MACD positive + RSI >50 OR pullback to $100.85-$97.45 with stabilization. Q3 2026 earnings mid-October serves as the decisive verdict on the $6.16 Q2 run-rate versus $7.80 consensus stress test (27% sequential growth requirement).

Outcome

✗

Return

-2.44%

Status

scored

Maintain SCHW at HOLD with position sizing at 3-4% (lighter end of neutral band given rising recession odds and stock at high end of 200-day SMA), hard stop at lower Bollinger band ~$105.29 (not $106.43 conservative or $99.50 aggressive), and cash-secured puts reduced to ~1/3 size at tighter $102 strike. Do NOT add or trim ahead of FOMC and CPI binary catalysts within the next 1-2 weeks. A binding Q3-earnings time-stop in mid-October requires a binary re-decision if neither Tier 1 ($100-102 pullback) nor Tier 2 ($113.44 breakout) entry triggers fire.

Outcome

✗

Return

+0.45%

Status

scored

Underweight rating on SCHW with a trim of 20-25% at $107 to reduce cyclical peak exposure while retaining core position for the 8% capital return yield. Hard stop set at $103 with remaining exposure capped at 1.5-2.0% of portfolio. Re-engagement requires stacked confirmation (close above $109.94 with MACD positive and RSI above 50), with mandatory re-evaluation at Q3 2026 earnings mid-October where the $6.16 Q2 run-rate versus $7.80 consensus requires 42% sequential growth to validate forward EPS math.

Outcome

✓

Return

+0.06%

Status

scored

Hold SCHW at $107.25 with explicit, binding decision rules that prevent passive underperformance. Maintain existing weight through the binary catalyst stack (Friday CPI, Sep 16-17 FOMC at 90% hike pricing, September retail gauge, Q3 earnings mid-October) without adding or trimming. Tighten hard stop to $104.85.

Outcome

✓

Return

-0.07%

Status

scored

Maintain HOLD on SCHW at $107.33 with no pre-FOMC trim or fresh adds absent triggers. Tighten the stop to $104.85 (a calibrated buffer below the 50 SMA at $105.83) and codify three explicit rules: add on close above $108.40 with positive MACD histogram, trim 1/3 on close below $105.50, and full exit on close below $104.50, with a binding Q3 earnings time-stop forcing reassessment if no triggers fire.

Outcome

✗

Return

+0.74%

Status

scored

Underweight SCHW at $107.50 with a 28-30% trim reducing exposure while maintaining 70-72% core position, with hard stop at $104.50 and structural invalidation at $110.40. Re-engagement requires three stacked confirmations: weekly close above $110 on volume >8M shares, MACD histogram positive, and RSI reclaiming 50. Position sizing on re-entry capped at 50% conviction until technical confirmation is achieved.

Outcome

✓

Return

-0.31%

Status

scored

Hold SCHW at $106.87, maintaining the existing position given the earnings ramp and $10B buyback but avoiding fresh capital deployment at current elevated levels—deploy 1–1.5% starter positions only on confirmation-based triggers. Define $100–102 as the asymmetric add zone, trim 15–20% on any rally into $109–110, and establish hard downgrade triggers at the 50 SMA break ($104.50) and Polymarket no-cut probability below 60%.

Outcome

✗

Return

-2.21%

Status

scored

Maintain Hold on SCHW at $109.29 as the consensus view of three of four analytical perspectives. For existing holders, retain positions given intact fundamentals (20.3% ROE, 42% YoY EPS growth, ~7% annualized capital return) and capital return yield; do not chase with full sizing given bearish technical posture (MACD at -0.59, RSI at 53, ATR compressing) and near 52-week highs creating unfavorable risk/reward (~4% downside to ~4% upside). Deploy new capital via a three-tier graduated architecture: 1% starter at current levels, 1-1.5% on pullback to $104-106 with RSI >45 and MACD bottoming OR breakout above $113.65 with volume >8M shares, and 1% on deep pullback <$104 with reversal or breakout >$115. Hard stop at $103.80 on Tier 1, $102.50 on full averaged position; maximum exposure capped at 5%.

Outcome

–

Return

-0.99%

Status

scored

Overweight SCHW with disciplined staged entry through September 12, avoiding initiation at current $110.38 price which exceeds the trader's $106-$108 entry zone; primary trigger is pullback to $106-$108 (1.0% position) while secondary trigger is close above $113.43 on >8M volume (0.5% starter), capped at 2% portfolio weight with hard stop at $96.78.

Outcome

✓

Return

+1.98%

Status

scored

Initiate an Overweight position in SCHW with a 2%/1%/1% scaled entry framework (max 4% total) that respects both the fundamental strength (13.9x forward P/E, 42.6% YoY EPS growth, 20.3% ROE, $14.8B annualized capital return) and the technical deterioration (10 EMA break, MACD bearish cross, RSI rollover from 76 to 51). Hard stop sits at $102.50 (50 SMA), with re-evaluation triggers tied to Q3 2026 earnings mid-October and Polymarket no-cut probability above 60%.

Outcome

✓

Return

-0.04%

Status

scored

Maintain HOLD on SCHW at current levels while locking in ~4.8% cumulative alpha from prior trims; the thesis is supported by intact fundamentals (42% EPS growth, 89% no-cut regime) but constrained by technical momentum reset (MACD bearish cross, RSI rollover to 51) and unfavorable risk-reward (+4.3% probability-weighted return vs 8-10% cost of equity). Use dynamic trim into confirmed strength and tiered re-engagement starting with a 25-33% starter position at $108-110, full add only on confirmed close above $114.53 with MACD histogram positive.

Outcome

✗

Return

-1.40%

Status

scored

Analysts unanimously recommend HOLD at $109.82, preserving the residual position trimmed on 8/25 while awaiting technical confirmation before adding. Entry triggers include MACD re-cross above the 10 EMA at $110.11 with volume, or a successful test of the $104-105 zone with reversal; the $103 stop below the 50 SMA remains the structural breakdown level. Re-evaluation is scheduled after September FOMC and Q3 earnings (mid-October), with fresh capital limited to a 1-2% starter position until price confirms the thesis.

Outcome

✓

Return

-0.31%

Status

scored

The consensus HOLD rating for SCHW is maintained across all analyst types except the Aggressive Analyst, with unanimous agreement that existing positions should be preserved without adding capital in the $108-110 zone. A tiered re-engagement framework with three explicit triggers (breakout above $113.82, pullback to $105-107, or deep pullback to $96-100/breakout above $115) awaits confirmation, with Q3 2026 earnings in mid-October serving as the critical thesis hinge to validate whether the NIM tailwind translates to the $6.16 EPS run-rate versus $7.80 consensus expectation.

Outcome

✗

Return

+1.95%

Status

scored

Underweight SCHW with 35-40% trim executed in two tranches: half at current $108 levels, half on any test toward $110-112 zone to eliminate dependency on a relief bounce. Stop residual at $100.50 (below 50 SMA at $102.76 with buffer), with re-entry on either close above $110 with rising volume OR successful 50 SMA test with bullish reversal candle and RSI curling above 50. Sell covered calls against residual position into Jackson Hole and Q3 earnings to capture rich IV premium. Re-evaluate after binary catalysts print; quality franchise prevents full Sell but deteriorating technicals, dated NIM tailwind asymptote, and Vanguard-Altruist overhang prevent fresh Buy.

Outcome

–

Return

-1.22%

Status

scored

SCHW is rated Overweight with a 6-12 month horizon anchored to the Q3 2026 earnings catalyst; entry is staged in the $105-108 zone over 3-4 weeks rather than chased at $109, with a hard closing stop at $102 (below 50 SMA). Position sizing is 2.5-3% of portfolio (1.5x benchmark), with 25% trims planned at $118-120 and another 25% at $125, holding remainder for $130+; 2-3% of NAV in protective puts (Dec/Jan $105-108 strikes) serves as tail insurance into earnings.

Outcome

✓

Return

-2.57%

Status

scored

Trim SCHW 40-50% (45% midpoint) across the $113.50-$115.00 resistance zone with partial market execution on intraday rejection at $114.50, based on unanimous analyst agreement on directional reduction following a 34% rally, MACD histogram collapse from 3.27 to 0.03, and distribution-day reversal at the upper Bollinger Band ($114.53); residual position protected by $107.50 daily-close stop, with conditional reload triggers requiring 2-of-3 confirmation (daily close above 10 EMA with MACD confirmation for downside reload, or close above $114.53 with volume >7M and RSI >76 for upside reload), and re-evaluation scheduled after Jackson Hole/FOMC with strategic anchor at Q3 2026 earnings.

Outcome

✗

Return

-1.21%

Status

scored

Maintain SCHW at HOLD—do not add at $113.65 where RSI 73.7 and MACD histogram compressed 92% from peak signal an extended technical setup. Stage entry at $110.50 (first tranche) and $108.50 (second tranche), reserving 50% for the $101-103 zone if MACD turns negative. Layer in 1-2% protective puts (Dec/Jan $105-108 strikes) as tail insurance ahead of the Q3'2026 earnings catalyst in mid-October.

Outcome

✗

Return

+1.20%

Status

scored

Maintain SCHW exposure at Hold; the 99th-percentile $112 entry with visible momentum cracks (MACD histogram compressed from +0.30 to +0.01, lowest-volume 5.15M breakout) violates the binding 8/18 lesson, while the trader's $107.84 mechanism captures the "minor consolidation" framework from 8/20 without waiting for deep retracements that never materialize. Set first add trigger at $107.84-$109.97 with hard stop $107.39 and trail existing position at $109.97 (10 EMA).

Outcome

✗

Return

+2.29%

Status

scored

Hold SCHW at ~$109 while preserving core overweight exposure; reject the trader's Buy proposal as mechanically identical to the 8/18 Overweight error. Technical setup (RSI 65 rolling over, MACD -0.03 bearish crossover, declining volume on upper Bollinger rejection) is structurally identical to the 8/18 configuration that produced -0.9% alpha. Add only on pullback to the research manager's own preferred accumulation zone of $100-107, or on confirmed Q3 2026 earnings that validates the $7.80 consensus EPS target against the $6.16 annualized Q2 run-rate.

Outcome

✗

Return

-0.98%

Status

scored

Maintain SCHW exposure at $110.88 with a HOLD rating as the technical setup (RSI 71, MACD contracting, 1.9% below resistance at $112.96) is too extended for fresh adds while the structural bull case remains valid. The 8/18 Overweight lesson is binding—adding at extended prices while maintaining overweight sizing is counterproductive—and the prior trim accumulation is already expressed, leaving HOLD as the calibrated synthesis. Trail stops to $109.37 with full exit on weekly close below $95.88 (200 SMA); new capital waits for the $100-$107 zone ahead of Q3 2026 earnings that will test the $6.16 EPS run-rate against $7.80 consensus estimates.

Outcome

✗

Return

-0.72%

Status

scored

SCHW maintains an Overweight rating with a patient limit order strategy, placing a GTC buy order at $106.36 for an initial 0.5% tranche rather than chasing the current price of $111.68. The decision synthesizes the aggressive analyst's strong fundamental thesis (42.6% EPS growth, 20.27% ROE, $13B capital return) with the conservative analyst's technical caution (RSI at 75.61, 33% rally off May low), while endorsing the trader's patient mechanism as the correct execution discipline. Existing core positions remain unchanged, with second and third tranches contingent on breakout confirmation above $112.77 and post-Q3 2026 earnings validation respectively.

Outcome

✓

Return

+0.99%

Status

scored

Hold SCHW at $110.58 as the unanimous recommendation across all analysts; maintain existing exposure without adding at current levels or further reducing. Enter new single-tranche positions only on pullback to $108.45 (10 EMA with RSI 55-60) or confirmed close above $112.32 with volume expansion, with hard stop at $99.35 (50 SMA) and tighter tactical stop at $106.50 for any new tranche.

Outcome

✓

Return

-0.46%

Status

scored

Maintain core SCHW position at $111; do not add or trim. The unanimous HOLD is supported by four prior Underweight decisions producing essentially zero cumulative alpha, a stretched technical setup (RSI 75.80, MACD down 85%, price at 99th percentile), and fundamental quality (20.27% ROE, $13B annual capital return) that justifies retaining the core but rules out adding at current entry levels. The neutral analyst's parameterized framework — entry zone $98-104, stop $98.50, tiered trim triggers (5% on RSI >80, 5% on MACD negative), and full exit on close <50 SMA — provides the disciplined execution model for the HOLD.

Outcome

✓

Return

+0.94%

Status

scored

After four prior Underweight trims producing near-zero alpha (-0.0% to +1.3%), the directional bearish view is fully expressed and further reduction would compound prior sizing errors. The fundamental quality (20.27% ROE, 52.28% margins, $13B capital return) is too strong for Underweight, but the technical setup (RSI 73.81, Bollinger at 99%, 28% recent rally) and symmetric risk/reward at $110 eliminate Buy rationale. Hold existing position and scale in new capital only via two tranches: 1% on breakout above $111.20 with volume > 8M, or 1-1.5% on pullback to $105-107.

Outcome

–

Return

+0.66%

Status

scored

Maintain Underweight posture via the existing residual position from three prior Underweight decisions; do not take additional share reduction as 15-20% trims were 200-300bps over optimal. Pivot to put convexity by hedging residual event risk with short-dated puts at $103-104 strike (~1-1.5% position cost) ahead of CPI print and Q3 2026 earnings. Hard stop on residual at $98 (50 SMA). Asymmetric re-entry: pullback to $104-106 with RSI reset is primary entry (1-2% weight); confirmed breakout above $110.40 on volume is secondary (capped at 0.5-1%).

Outcome

✗

Return

+1.52%

Status

scored

Move SCHW to underweight and trim 15-20% in the $107-108 zone given a stretched technical setup (16.7% six-week rally, MACD rolling over, 70% volume collapse at highs) ahead of this week's August CPI print—a binary catalyst for NIM-sensitive financials. The stop on residual is $104.00-104.50, with re-add above $109.70 and full exit below $104 on rising volume. Fundamentals (20% ROE, $102B liquidity, $13B capital return, 51.88% operating margin) remain intact, warranting core exposure but not at current stretched levels.

Outcome

–

Return

-0.27%

Status

scored

Trim 25-30% of SCHW exposure into the $107-109 overbought zone while tightening the stop to $103-104, maintaining half-weight through the Aug 31 Hormuz resolution and Q3 2026 comp-lap earnings to test whether annualized EPS of $6.16 (from Q2's $1.54) can close its gap to the $7.80 required for the 13.8x forward P/E—re-enter first tranche at $104-105 on RSI reset to 55-60 with volume contraction, add second tranche only on confirmed MACD line cross above zero.

Outcome

–

Return

+0.36%

Status

scored

SCHW is rated Underweight with a 15-20% trim recommendation into the $107-108 resistance zone, maintaining a trailing stop at $103.86. New capital should not be deployed; tiered re-entry is planned at $105-106 on RSI cooling to 55-60, with a second tranche on MACD line crossing above zero. Consider hedging with 60-90 day puts at $100-102 into Q3 2026 earnings.